Gl. Mottla et al., INCREASING CLINICAL PREGNANCY RATES AFTER IVF ET - CAN IMMUNOSUPPRESSION HELP/, Journal of reproductive medicine, 41(12), 1996, pp. 889-891
OBJECTIVE: To evaluate the safety and efficacy of immunosuppression as
an adjunct to improving the success of in vitro fertilization/embryo
transfer (IVF-ET). STUDY DESIGN:A randomized, double-blind, placebo-co
ntrolled clinical trial. RESULTS: Seventy-five patients were randomize
d to receive either prednisone (39 patients, 51%) or placebo (36 patie
nts, 49%). Patients in both groups had similar ages and numbers of pre
embryos transferred. CONCLUSION: Both the implantation and clinical pr
egnancy rates were higher in the prednisone group (16% vs. 11% and 43.
5% vs. 32.3%, respectively). However, these differences did not achiev
e statistical significance. Evaluation of the ongoing pregnancy rate r
evealed little difference between the prednisone-treated patients (30.
7%) and those receiving placebo (28.0%). There were no side effects re
ported by patients in either group.